Citius Oncology Inc.CTORNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-551.25%
↓ 400% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
-110.25%
Historical baseline
PeriodValueYoY Change
TTM-551.25%-
20250.00%-
20240.00%-
20230.00%-
20220.00%-